Published in Acta Diabetol on August 07, 2008
Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence. Best Pract Res Clin Endocrinol Metab (2010) 2.89
Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study. Diabetes Care (2011) 1.70
Self-reported short sleep duration and frequent snoring in pregnancy: impact on glucose metabolism. Am J Obstet Gynecol (2010) 1.39
Does inadequate sleep play a role in vulnerability to obesity? Am J Hum Biol (2012) 1.30
Interacting epidemics? Sleep curtailment, insulin resistance, and obesity. Ann N Y Acad Sci (2012) 1.15
Sleep is associated with the metabolic syndrome in a multi-ethnic cohort of midlife women: the SWAN Sleep Study. Sleep (2012) 1.08
Loneliness is associated with sleep fragmentation in a communal society. Sleep (2011) 1.08
Impact of sleep duration on obesity and the glycemic level in patients with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetes Care (2012) 1.02
The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms. Diabetol Metab Syndr (2015) 1.00
Association between sleep deficiency and cardiometabolic disease: implications for health disparities. Sleep Med (2015) 0.84
Poor sleep quality is associated with increased arterial stiffness in Japanese patients with type 2 diabetes mellitus. BMC Endocr Disord (2015) 0.84
Sleep duration and glycemic control in patients with diabetes mellitus: Korea National Health and Nutrition Examination Survey 2007-2010. J Korean Med Sci (2013) 0.81
Disturbed subjective sleep in Chinese females with type 2 diabetes on insulin therapy. PLoS One (2013) 0.80
The negative effect of carpal tunnel syndrome on sleep quality. Sleep Disord (2014) 0.80
Contributions of Comorbid Diabetes to Sleep Characteristics, Daytime Symptoms, and Physical Function Among Patients With Stable Heart Failure. J Cardiovasc Nurs (2015) 0.76
Relationships between lifestyle patterns and cardio-renal-metabolic parameters in patients with type 2 diabetes mellitus: A cross-sectional study. PLoS One (2017) 0.75
Sleep, type 2 diabetes, dyslipidemia, and hypertension in elderly Alzheimer's caregivers. Arch Gerontol Geriatr (2013) 0.75
Sleep Optimization and Diabetes Control: A Review of the Literature. Diabetes Ther (2015) 0.75
Effects of sleep disruption and high fat intake on glucose metabolism in mice. Psychoneuroendocrinology (2016) 0.75
Effects of Sleep Disorders on Hemoglobin A1c Levels in Type 2 Diabetic Patients. Chin Med J (Engl) (2015) 0.75
Sleep Pattern, Duration and Quality in Relation with Glycemic Control in People with Type 2 Diabetes Mellitus. Iran J Med Sci (2016) 0.75
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell (1992) 6.86
Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia (2007) 2.52
Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up. Diabetes Care (2001) 2.45
Socioeconomic differences in cancer survival: a review of the evidence. IARC Sci Publ (1997) 2.33
A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab (2010) 2.33
Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial. Diabetologia (2002) 2.23
Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab (2001) 2.13
Impairment of GH secretion in adults with primary empty sella. J Endocrinol Invest (2002) 2.09
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med (1998) 2.08
Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry (2007) 2.03
Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab (2000) 1.83
Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia (1996) 1.70
Epidemiology: bridges over (and across) roaring levels. J Epidemiol Community Health (1998) 1.69
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. J Exp Med (2001) 1.66
Pancreatitis and the risk of pancreatic cancer. Pancreas (1995) 1.64
Poverty, health services, and health status in rural America. Milbank Q (1988) 1.61
Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease. Clin Endocrinol (Oxf) (2000) 1.60
Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med (2000) 1.56
Consensus statement: medical management of acromegaly. Eur J Endocrinol (2005) 1.54
First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group. J Endocrinol Invest (2006) 1.52
Screening and prevention of diabetic blindness. Acta Ophthalmol Scand (2000) 1.51
Ethics of ignorance: lessons from the epidemiological assessment of the bovine spongioform encephalopathy ("mad cow disease") epidemic. Perspect Biol Med (1998) 1.51
Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine (2013) 1.48
Success and failure at inpatient heroin detoxification. Br J Addict (1989) 1.48
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Clin Endocrinol (Oxf) (1999) 1.48
Circulating ghrelin levels in the newborn are positively associated with gestational age. Clin Endocrinol (Oxf) (2004) 1.44
Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest (2000) 1.44
Hypopituitaric patients with corticotropin insufficiency show marked impairment of the cortisol response to ACTH (1-24) independently of the duration of the disease. J Endocrinol Invest (2003) 1.43
An international comparison of knowledge levels of medical students: the Maastricht Progress Test. Med Educ (1996) 1.42
Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab (2004) 1.40
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? J Endocrinol Invest (2002) 1.40
Incidence and prevalence rate estimation of GH treatment exposure in Piedmont pediatric population in the years 2002-2004: Data from the GH Registry. J Endocrinol Invest (2006) 1.39
Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health (1998) 1.38
Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care (2001) 1.38
ACROSTUDY: the Italian experience. Endocrine (2014) 1.38
Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab (2001) 1.37
Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet (1982) 1.35
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab (2001) 1.32
Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts. Oncogene (1997) 1.31
Halogenated isoniazid derivatives as possible antitubercular and antineoplastic agents. Note 1. Farmaco (1992) 1.28
Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab (2004) 1.28
Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract (2006) 1.26
Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. ISDS II Project Investigators. Eur J Cancer (1994) 1.25
Ghrelin-induced growth hormone secretion in humans. Eur J Endocrinol (2000) 1.24
Primary empty sella: Why and when to investigate hypothalamic-pituitary function. J Endocrinol Invest (2010) 1.21
Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms. J Thromb Haemost (2007) 1.16
A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care (2000) 1.15
Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. Int J Cancer (1993) 1.15
Clinical assessment of hypermobility of joints: assembling criteria. J Rheumatol (1992) 1.13
Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology (1991) 1.13
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int J Obes Relat Metab Disord (1999) 1.11
A comparison of the alcohol-attributable mortality in four European countries. Eur J Epidemiol (2003) 1.11
IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. J Immunol (2001) 1.10
Current management practices for acromegaly: an international survey. Pituitary (2011) 1.10
Detection and morphology of thymic remnants after video-assisted thoracoscopic extended thymectomy (VATET) in patients with myasthenia gravis. Int Surg (1996) 1.09
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08
Bone metabolism in type 2 diabetes mellitus. Acta Diabetol (1999) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Differential activation by Ca2+, ATP and caffeine of cardiac and skeletal muscle ryanodine receptors after block by Mg2+. J Membr Biol (2002) 1.07
Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia (1981) 1.07
Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol (2005) 1.06
Trends in pancreatic cancer mortality in Europe, 1955-1989. Int J Cancer (1994) 1.06
Reliability of death certifications for different types of cancer. An autopsy survey. Pathol Res Pract (1986) 1.06
Clinical assessment of dysphagia in early phases of Parkinson's disease. Neurol Sci (2002) 1.05
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
Free-living amoebae, a training field for macrophage resistance of mycobacteria. Clin Microbiol Infect (2009) 1.05
Gallstone ileus: One-stage surgery in an elderly patient: One-stage surgery in gallstone ileus. Int J Surg Case Rep (2013) 1.05
C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up. Eur J Endocrinol (2012) 1.04
Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf) (2005) 1.04
New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel. Eye (Lond) (2012) 1.04
Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients. Diabetes Obes Metab (2011) 1.04
The neonatal management and surgical correction of urinary hydrometrocolpos caused by a persistent urogenital sinus. BJU Int (1999) 1.03
Video-assisted thoracoscopic extended thymectomy (VATET) in myasthenia gravis. Two-year follow-up in 101 patients and comparison with the transsternal approach. Ann N Y Acad Sci (1998) 1.03
Circulating cytokine balance and activation markers of leucocytes in Q fever. Clin Exp Immunol (1999) 1.03
Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators. Int J Cancer (1997) 1.02
Improvement in survival after myocardial infarction between 1978-85 and 1986-88 in the REGICOR study. (Registre GIroní del COR) registry. Eur Heart J (1995) 1.02
Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis (2005) 1.02
Brain perfusion CT: principles, technique and clinical applications. Radiol Med (2007) 1.00
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. Cancer Res (2000) 1.00
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population. J Endocrinol Invest (2008) 0.99
Melatonin reduces oxidative stress in surgical neonates. J Pediatr Surg (2004) 0.99
Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells. Cancer Res (1987) 0.99
Cytokine stimulated endothelin release from endothelial cells. Life Sci (1991) 0.99